{"id":551286,"date":"2024-09-11T20:17:05","date_gmt":"2024-09-12T03:17:05","guid":{"rendered":"https:\/\/nai500.com\/?p=551286"},"modified":"2024-09-11T20:29:41","modified_gmt":"2024-09-12T03:29:41","slug":"%e5%85%a8%e7%90%83%e8%90%a5%e6%94%b6%e5%89%8d%e5%8d%81%e7%9a%84%e5%88%b6%e8%8d%af%e5%85%ac%e5%8f%b8%ef%bc%882024%e5%b9%b4%e6%9b%b4%e6%96%b0%ef%bc%89","status":"publish","type":"post","link":"https:\/\/nai500.com\/zh-hans\/blog\/2024\/09\/%e5%85%a8%e7%90%83%e8%90%a5%e6%94%b6%e5%89%8d%e5%8d%81%e7%9a%84%e5%88%b6%e8%8d%af%e5%85%ac%e5%8f%b8%ef%bc%882024%e5%b9%b4%e6%9b%b4%e6%96%b0%ef%bc%89\/","title":{"rendered":"\u5168\u7403\u8425\u6536\u524d\u5341\u7684\u5236\u836f\u516c\u53f8\uff082024\u5e74\u66f4\u65b0\uff09"},"content":{"rendered":"<p>\u5236\u836f\u884c\u4e1a\u662f\u836f\u7269\u7814\u53d1\u3001\u5546\u4e1a\u5316\u548c\u8425\u9500\u7684\u57fa\u77f3\u3002\u636eStatista\u7edf\u8ba1\uff0c\u5236\u836f\u884c\u4e1a\u7684\u8425\u6536\u9996\u6b21\u57282014\u5e74\u7a81\u78341\u4e07\u4ebf\u7f8e\u5143\u5e76\u7a33\u6b65\u5347\u81f32023\u5e74\u76841.6\u4e07\u4ebf\u7f8e\u5143\uff0c\u5176\u4e2d\u5317\u7f8e\u5730\u533a\u4f9d\u9760\u7f8e\u56fd\u5e9e\u5927\u7684\u5236\u836f\u5e02\u573a\u589e\u957f\u5c24\u4e3a\u663e\u8457\u3002Evaluate Pharma\u9884\u8ba1\uff0c\u4ec5\u5904\u65b9\u836f\u7684\u9500\u552e\u989d\u52302030\u5e74\u5c31\u5c06\u8fbe\u52301.7\u4e07\u4ebf\u7f8e\u5143\u3002\u90a3\u4e48\uff0c\u54ea\u4e9b\u516c\u53f8\u5728\u63a8\u52a8\u5236\u836f\u9886\u57df\u7684\u589e\u957f\u548c\u521b\u65b0\u5462\uff1f<\/p>\n<p>\u4ee5\u4e0b\u662f\u6839\u636eFierce Pharma\u63d0\u4f9b\u7684\u6570\u636e\u7f16\u5236\u800c\u6210\u7684\u5168\u7403\u8425\u6536\u524d\u5341\u7684\u5236\u836f\u516c\u53f8\u6982\u51b5\u3002<\/p>\n<h2>1.\u00a0\u00a0 <a href=\"https:\/\/nai500.com\/zh-hans\/%e8%82%a1%e7%a5%a8%e6%9f%a5%e8%af%a2\/?qm_symbol=JNJ\">\u5f3a\u751f\u516c\u53f8\uff08Johnson &amp; Johnson\uff09\uff08NYSE:JNJ\uff09<\/a><\/h2>\n<ul>\n<li>2023\u5e74\u8425\u6536\uff1a851.6\u4ebf\u7f8e\u5143<\/li>\n<li>\u5f3a\u751f\u4ee5\u5176\u5728\u5236\u836f\u548c\u533b\u7597\u8bbe\u5907\u9886\u57df\u7684\u7814\u53d1\u3001\u5236\u9020\u548c\u9500\u552e\u6d3b\u52a8\u800c\u8457\u79f0\u3002\u53bb\u5e74\uff0c\u5f3a\u751f\u5c06\u5176\u6d88\u8d39\u8005\u5065\u5eb7\u90e8\u95e8\u5206\u62c6\u6210\u4e00\u4e2a\u540d\u4e3aKenvue\u7684\u65b0\u516c\u53f8\u3002\u8be5\u516c\u53f8\u4e13\u6ce8\u4e8e\u4e94\u4e2a\u4e3b\u8981\u6cbb\u7597\u9886\u57df\uff1a\u514d\u75ab\u3001\u4f20\u67d3\u75c5\u548c\u75ab\u82d7\u3001\u795e\u7ecf\u79d1\u5b66\u3001\u80bf\u7624\u4ee5\u53ca\u5fc3\u8840\u7ba1\u548c\u4ee3\u8c22\u75be\u75c5\u30022023\u5e74\uff0c\u516c\u53f8\u836f\u54c1Tremfya\u7684\u9500\u552e\u989d\u589e\u957f18%\u81f331.5\u4ebf\u7f8e\u5143\uff0c\u514d\u75ab\u836f\u7269Stelara\u7684\u9500\u552e\u989d\u4e5f\u6709\u6240\u589e\u52a0\uff0c\u4f46\u660e\u5e74\u5c06\u9762\u4e34\u751f\u7269\u4eff\u5236\u836f\u7684\u7ade\u4e89\u3002\u516c\u53f8\u7ba1\u7406\u5c42\u9884\u6d4b2025-2030\u5e74\u7684\u5e74\u589e\u901f\u57285%-7%\u4e4b\u95f4\u3002<\/li>\n<\/ul>\n<h2>2.\u00a0\u00a0 \u7f57\u6c0f\u63a7\u80a1\uff08Roche Holding\uff09\uff08OTCQX:RHHBF, SWX:RO\uff09<\/h2>\n<ul>\n<li>2023\u5e74\u8425\u6536\uff1a653.2\u4ebf\u7f8e\u5143<\/li>\n<li>\u7f57\u6c0f\u603b\u90e8\u4f4d\u4e8e\u745e\u58eb\u5df4\u585e\u5c14\uff0c\u62e5\u6709\u5236\u836f\u548c\u8bca\u65ad\u4e24\u4e2a\u4e3b\u8981\u90e8\u95e8\u3002\u5c3d\u7ba1\u7531\u4e8e\u745e\u58eb\u6cd5\u90ce\u8d70\u5f3a\u5bfc\u81f4\u603b\u8425\u6536\u540c\u6bd4\u4e0b\u964d7.2%\uff0c\u4f46\u5176\u773c\u79d1\u836f\u7269Vabysmo\u8868\u73b0\u4f18\u5f02\uff0c\u6210\u4e3a\u5176\u4ea7\u54c1\u7ec4\u5408\u4e2d\u7684\u660e\u661f\u4ea7\u54c1\u3002<\/li>\n<\/ul>\n<h2>3.\u00a0\u00a0 \u9ed8\u514b\u516c\u53f8\uff08Merck &amp; Company\uff09\uff08NYSE:MRK\uff09<\/h2>\n<ul>\n<li>2023\u5e74\u8425\u6536\uff1a601\u4ebf\u7f8e\u5143<\/li>\n<li>\u4e3b\u8981\u6cbb\u7597\u9886\u57df\u5305\u62ec\u7cd6\u5c3f\u75c5\u3001\u764c\u75c7\u548c\u591a\u53d1\u6027\u786c\u5316\u75c7\u7b49\uff0c\u68c0\u67e5\u70b9\u6291\u5236\u5242Keytruda 2023\u5e74\u7684\u5168\u7403\u9500\u552e\u989d\u589e\u957f19%\u81f3250\u4ebf\u7f8e\u5143\uff0c\u6210\u4e3a\u5168\u7403\u6700\u7545\u9500\u836f\u54c1\u3002<\/li>\n<\/ul>\n<h2>4.\u00a0\u00a0 \u8f89\u745e\u516c\u53f8\uff08Pfizer\uff09\uff08NYSE:PFE\uff09<\/h2>\n<ul>\n<li>2023\u5e74\u8425\u6536\uff1a585\u4ebf\u7f8e\u5143<\/li>\n<li>\u8f89\u745e2023\u5e74\u7684\u8425\u6536\u51cf\u5c11\u4e8641%\uff0c\u4e3b\u8981\u7531\u4e8eCOVID-19\u76f8\u5173\u4ea7\u54c1\u6536\u5165\u7684\u4e0b\u964d\u3002\u4f46\u5982\u679c\u6263\u9664\u8fd9\u4e9b\u4ea7\u54c1\uff0c\u516c\u53f8\u836f\u54c1\u9500\u552e\u989d\u589e\u957f7%\u3002<\/li>\n<\/ul>\n<h2>5.\u00a0\u00a0 \u827e\u4f2f\u7ef4\u516c\u53f8\uff08AbbVie\uff09\uff08NYSE:ABBV\uff09<\/h2>\n<ul>\n<li>2023\u5e74\u8425\u6536\uff1a543\u4ebf\u7f8e\u5143<\/li>\n<li>\u4ee5\u7814\u53d1\u7528\u4e8e\u6162\u6027\u81ea\u8eab\u514d\u75ab\u75be\u75c5\u3001\u795e\u7ecf\u7cfb\u7edf\u75be\u75c5\u4ee5\u53ca\u4ee3\u8c22\u75be\u75c5\u7684\u836f\u7269\u800c\u8457\u79f0\u3002Humira\u5728\u7f8e\u56fd\u5931\u53bb\u5e02\u573a\u72ec\u5360\u5730\u4f4d\u540e\uff0c\u516c\u53f8\u9500\u552e\u989d\u589e\u957f\u5c06\u66f4\u52a0\u4f9d\u8d56\u4e8e\u5176\u514d\u75ab\u836f\u7269Skyrizi\u548cRinvoq\u3002<\/li>\n<\/ul>\n<h2>6.\u00a0\u00a0 \u8d5b\u8bfa\u83f2\u516c\u53f8\uff08Sanofi\uff09\uff08NASDAQ:SNY\uff09<\/h2>\n<ul>\n<li>2023\u5e74\u8425\u6536\uff1a466\u4ebf\u7f8e\u5143<\/li>\n<li>\u516c\u53f8\u9886\u8854\u7684\u6536\u5165\u6765\u6e90\u662fDupixent\u836f\u7269\uff0c\u8fd1\u5e74\u6765\u83b7\u5f97\u4e86\u591a\u4e2a\u9002\u5e94\u75c7\u7684\u6279\u51c6\u3002<\/li>\n<\/ul>\n<h2>7.\u00a0\u00a0 \u963f\u65af\u5229\u5eb7\u516c\u53f8\uff08AstraZeneca\uff09\uff08NASDAQ:AZN\uff09<\/h2>\n<ul>\n<li>2023\u5e74\u8425\u6536\uff1a458.1\u4ebf\u7f8e\u5143<\/li>\n<li>\u516c\u53f8\u5728\u591a\u4e2a\u6cbb\u7597\u9886\u57df\u7684\u5408\u4f5c\u63a8\u52a8\u5176\u8425\u6536\u589e\u957f3.3%\uff0c\u5176\u4e2d\u80bf\u7624\u4e1a\u52a1\u7684\u9500\u552e\u989d\u589e\u957f20%\u81f3171\u4ebf\u7f8e\u5143\u3002<\/li>\n<\/ul>\n<h2>8.\u00a0\u00a0 \u8bfa\u534e\u516c\u53f8\uff08Novartis\uff09\uff08NYSE:NVS, SWX:NOVN\uff09<\/h2>\n<ul>\n<li>2023\u5e74\u8425\u6536\uff1a454.4\u4ebf\u7f8e\u5143<\/li>\n<li>\u53bb\u5e74\uff0c\u8bfa\u534e\u5206\u62c6\u5176\u4eff\u5236\u836f\u548c\u751f\u7269\u4eff\u5236\u836f\u516c\u53f8Sandoz\uff0c\u6210\u4e3a\u4e86\u4e00\u5bb6\u521b\u65b0\u836f\u54c1\u516c\u53f8\u30022023\u5e74\u8425\u6536\u589e\u957f7.7%\u3002<\/li>\n<\/ul>\n<h2>9.\u00a0\u00a0 \u767e\u65f6\u7f8e\u65bd\u8d35\u5b9d\u516c\u53f8\uff08Bristol-Myers Squibb Company\uff09\uff08NYSE:BMY\uff09<\/h2>\n<ul>\n<li>2023\u5e74\u8425\u6536\uff1a450\u4ebf\u7f8e\u5143<\/li>\n<li>\u516c\u53f8\u6b63\u5904\u4e8e\u8f6c\u578b\u671f\uff0c\u9762\u5bf9\u4e13\u5229\u60ac\u5d16\u548c\u653f\u7b56\u53d8\u5316\uff08\u300a\u901a\u80c0\u524a\u51cf\u6cd5\u6848\u300b\u7684\u836f\u4ef7\u8c08\u5224\u5c06\u4e8e2026\u5e74\u751f\u6548\uff09\u7684\u6311\u6218\u3002\u968f\u7740\u6700\u5927\u836f\u54c1Revlimid\u6162\u6162\u5931\u52bf\uff0c\u516c\u53f8\u672a\u6765\u6536\u5165\u589e\u957f\u5c06\u4f9d\u8d56\u4e8e\u91cd\u78c5\u836fEliquis\u548cOpdivo\u3002<\/li>\n<\/ul>\n<h2>10. \u845b\u5170\u7d20\u53f2\u514b\u516c\u53f8\uff08GSK\uff09\uff08NYSE:GSK, LSE:GSK\uff09<\/h2>\n<ul>\n<li>2023\u5e74\u8425\u6536\uff1a384\u4ebf\u7f8e\u5143<\/li>\n<li>\u516c\u53f8\u5206\u4e09\u5927\u4e1a\u52a1\u677f\u5757\uff1a\u5236\u836f\u3001\u6d88\u8d39\u8005\u5065\u5eb7\u548c\u75ab\u82d7\uff0c\u5176\u4e2d\u5e26\u72b6\u75b1\u75b9\u75ab\u82d7Shingrix\u662f\u4e3b\u8981\u589e\u957f\u52a8\u529b\uff0c\u589e\u957f17%\u5e76\u5e26\u52a8\u516c\u53f8\u8425\u6536\u589e\u957f3.4%\u3002\u53bb\u5e74\u65b0\u6279\u51c6\u7684\u547c\u5438\u9053\u5408\u80de\u75c5\u6bd2\uff08RSV\uff09\u75ab\u82d7Arexvy\u6709\u671b\u6210\u4e3a\u65b0\u7684\u589e\u957f\u9a71\u52a8\u529b\u3002<\/li>\n<\/ul>\n","protected":false},"excerpt":{"rendered":"<p>\u5236\u836f\u884c\u4e1a\u662f\u836f\u7269\u7814\u53d1\u3001\u5546\u4e1a\u5316\u548c\u8425\u9500\u7684\u57fa\u77f3\u3002\u636eStatista\u7edf\u8ba1\uff0c\u5236\u836f\u884c\u4e1a\u7684\u8425\u6536\u9996\u6b21\u57282014\u5e74\u7a81\u78341\u4e07\u4ebf\u7f8e\u5143\u5e76 [&hellip;]<\/p>\n","protected":false},"author":27,"featured_media":551300,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":"","_links_to":"","_links_to_target":""},"categories":[1521,430],"tags":[513,455,747,925],"class_list":["post-551286","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-1521","category-trends-strategies-zh-hans","tag-513","tag-455","tag-747","tag-925","sectors-life-science-zh-hans","locations-us-zh-hans","exchange-nasdaq-zh-hans","exchange-nyse-zh-hans"],"acf":[],"_links":{"self":[{"href":"https:\/\/nai500.com\/zh-hans\/wp-json\/wp\/v2\/posts\/551286","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/nai500.com\/zh-hans\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/nai500.com\/zh-hans\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/nai500.com\/zh-hans\/wp-json\/wp\/v2\/users\/27"}],"replies":[{"embeddable":true,"href":"https:\/\/nai500.com\/zh-hans\/wp-json\/wp\/v2\/comments?post=551286"}],"version-history":[{"count":7,"href":"https:\/\/nai500.com\/zh-hans\/wp-json\/wp\/v2\/posts\/551286\/revisions"}],"predecessor-version":[{"id":551309,"href":"https:\/\/nai500.com\/zh-hans\/wp-json\/wp\/v2\/posts\/551286\/revisions\/551309"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/nai500.com\/zh-hans\/wp-json\/wp\/v2\/media\/551300"}],"wp:attachment":[{"href":"https:\/\/nai500.com\/zh-hans\/wp-json\/wp\/v2\/media?parent=551286"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/nai500.com\/zh-hans\/wp-json\/wp\/v2\/categories?post=551286"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/nai500.com\/zh-hans\/wp-json\/wp\/v2\/tags?post=551286"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}